Who
Mark J. Rosenblum
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Decoy Therapeutics; Chief Financial Officer, Advaxis; Chief Financial Officer, Hemobiotech.
In numbers
- Trades disclosed
- 43
- Buys
- 7
- Sells
- 0
- Bought
- $110K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 31 Mar 2006
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,682 at $0.00 | filing |
| 31 Aug 2026filed 2 Sep 2026 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,682 at $0.00 | filing |
| 20 Nov 2025filed 20 Nov 2025 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $16K20,000 at $0.80 | filing |
| 20 Feb 2024filed 22 Feb 2024 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 13 Feb 2023filed 15 Feb 2023 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,432 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 3 Nov 2022filed 12 Dec 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,5741,488 at $1.73 | filing |
| 3 Nov 2022filed 8 Nov 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K7,314 at $1.73 | filing |
| 3 Nov 2022filed 7 Nov 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K7,314 at $1.73 | filing |
| 31 May 2022filed 31 May 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,04028,000 at $0.18 | filing |
| 3 May 2022filed 5 May 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $1,90010,000 at $0.19 | filing |
| 3 Mar 2022filed 9 Mar 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $30K76,246 at $0.39 | filing |
| 20 Jan 2022filed 21 Jan 2022 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 3 Nov 2021filed 5 Nov 2021 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $5,6077,787 at $0.72 | filing |
| 3 May 2021filed 5 May 2021 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $5,4519,563 at $0.57 | filing |
| 2 Dec 2020filed 4 Dec 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 3 Nov 2020filed 5 Nov 2020 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,6454,723 at $0.56 | filing |
| 17 Aug 2020filed 18 Aug 2020 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,0005,000 at $1.00 | filing |
| 14 Jul 2020filed 16 Jul 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,955 at $0.00 | filing |
| 23 Mar 2020filed 25 Mar 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.